한글목차

세계의 중입자선 치료 기술 시장 규모는 2024년에 6억 3,200만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 19.6%로 성장하며, 2031년까지 23억 5,800만 달러로 확대할 것으로 예측되고 있습니다.

중입자 치료 기술, 즉 중입자 방사선 치료(HIR)는 가속된 중입자(주로 탄소 이온)를 이용해 종양을 정밀하게 표적화하여 파괴하는 첨단 암 치료법입니다. 이 방식은 중입자 특유의 물리적, 생물학적 특성을 활용함으로써 기존 방사선 치료와 차별화를 꾀하고 있습니다. HIR은 탄소 이온 및 기타 중이온을 광속의 상당 부분까지 가속합니다. 이러한 고에너지 이온을 종양에 조사하여 암세포에 직접적으로 집중적인 방사선량을 전달합니다. 체내 전 경로를 따라 에너지를 방출하는 기존 엑스레이 치료와 달리 중입자선 치료는 독특한 에너지 방출 패턴을 보입니다. 방사선량은 깊이에 따라 증가하며, 브래그 피크라고 불리는 특정 지점에서 최대치에 도달합니다. 이 피크는 종양내 정확한 위치에 설정할 수 있습니다. 이를 통해 방사선 조사를 고도로 표적화하여 주변 정상 조직에 대한 손상을 최소화할 수 있습니다. 이 보고서는 중입자 치료 기술 시장을 위한 장비에 초점을 맞추었습니다.

기존의 중입자선 치료 기술 장비는 탄소 이온만을 사용했으나, 다이온 치료는 특정 악성 종양에 최적화된 다양한 이온빔을 조합하여 부작용을 줄이면서 더 많은 암세포를 사멸시킬 수 있습니다. 2022년, QST와 SHI는 네온, 산소, 헬륨 이온 등을 이용한 다이온원 개발에 성공하여 다이온 방사선 치료의 실현에 한 발짝 더 다가섰습니다. 이 시스템은 추가 연구를 위해 QST의 치바에 위치한 중입자 의료용 가속기(HIMAC)에 설치되었습니다. 새로운 시스템에서는 탄소보다 무거운 산소를 종양 중심부에 조사하고, 탄소보다 가벼운 헬륨을 정상 조직에 가까운 부위에 조사했습니다. 용량 분포와 생물학적 효과의 분포도 분석되었습니다. 탄소이온 단독 조사 사례와 비교하여 다른 이온빔의 병용이 더 효과적이라는 것을 확인했습니다. 육종의 수술적 치료는 수술 부위에 따라 신경손상(신경장애)이 발생하는 경우가 많습니다. 중입자선 치료는 수술이 어려운 환자들에게도 좋은 결과를 얻고 있습니다. 또한 매우 큰 종양의 치료에서는 재발이 자주 문제가 되었습니다. 다 이온 요법을 이용한 첫 번째 사례는 2023년 11월-12월에 실시되었으며, 동일 환자에게 16회 조사했습니다. 탄소선과 산소선을 같은 날 조사하는 것이 최초로 실현되었으며, 양자의 전환도 원활하게 이루어졌습니다. 환자는 치료 종료 다음날 퇴원했으며, 2개월 후 경과 관찰에서도 초기 부작용은 나타나지 않았습니다.

이 보고서는 중입자선 치료 기술 세계 시장에 대해 총매출액, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

중입자선 치료 기술 시장 규모 추정 및 예측은 매출액 기준으로 제시되며, 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 포함하고 있습니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 중입자 치료 기술에 대한 정보에 입각한 비즈니스 의사결정을 내리는데 도움을 드리고자 합니다.

시장 세분화

기업별

• Toshiba
• Hitachi
• CASHIM
• Sumitomo Heavy Industries(SHI)
• Siemens(Varian)

유형별 부문

• 중입자선 치료 시스템
• 양자선 치료 시스템
• 기타

용도별 부문

• 병원
• 연구기관

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동 및 아프리카

영문목차

The global market for Heavy Ion Therapy Technology was estimated to be worth US$ 632 million in 2024 and is forecast to a readjusted size of US$ 2358 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.

Heavy Ion Therapy Technology, or Heavy ion radiotherapy (HIR) is a sophisticated form of cancer treatment that employs accelerated heavy ions, most commonly carbon, to precisely target and destroy tumors. This method distinguishes itself from traditional radiotherapy by leveraging the unique physical and biological properties of these heavy ions. In HIR, carbon or other heavy ions are accelerated to a substantial fraction of the speed of light. These high-energy ions are then directed towards the tumor, delivering a concentrated dose of radiation directly to the cancerous cells. Unlike conventional X-ray therapy, which deposits energy along its entire path through the body, heavy ion therapy exhibits a distinct energy deposition pattern. The radiation dose increases with depth, reaching a maximum at a specific point known as the Bragg peak, which can be precisely positioned within the tumor. This allows for a highly targeted delivery of radiation, minimizing damage to surrounding healthy tissues. This report focuses on the devices for heavy ion therapy technology market.

In conventional heavy-particle radiotherapy equipment, only carbon ions are used. In multi-ion therapy, on the other hand, various kinds of ion beams-optimal for the specific malignancy-are combined to kill more cancer cells with fewer side effects. In 2022, QST and SHI succeeded in creating a multi-ion source, using neon, oxygen, and helium ions among others, making multi-ion radiotherapy possible. The system was installed at QST's Heavy Ion Medical Accelerator in Chiba (HIMAC) for further research. With the new system, oxygen, heavier than carbon, was irradiated to the center of a tumor, and helium, lighter than carbon, was irradiated to an area nearer to normal tissue. Dose distribution and distribution of biological effects were also analyzed. Through a comparison with cases where only carbon ions were irradiated, it was confirmed that using different ion beams was more effective. In surgical treatments for sarcoma, depending on the site of the operation, patients often experience nerve injuries (neuropathy). Satisfactory results have been obtained using heavy ions, even for those patients for whom surgery would not have been possible. Moreover, in treatments of very large tumors, recurrence has been a frequent problem. The first case using multi-ion therapy occurred in November and December 2023, involving irradiation applied on the same patient 16 times. For the first time, carbon and oxygen irradiations were done on the same day, and switching between them was conducted smoothly. The patient was discharged the day after the treatments ended, and no early side effects were seen two months later.

This report aims to provide a comprehensive presentation of the global market for Heavy Ion Therapy Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Heavy Ion Therapy Technology by region & country, by Type, and by Application.

The Heavy Ion Therapy Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heavy Ion Therapy Technology.

Market Segmentation

By Company

• Toshiba
• Hitachi
• CASHIM
• Sumitomo Heavy Industries (SHI)
• Siemens (Varian)

Segment by Type

• Heavy Ion Therapy System
• Protons Therapy System
• Others

Segment by Application

• Hospital
• Research Institute

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Heavy Ion Therapy Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Heavy Ion Therapy Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Heavy Ion Therapy Technology in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Heavy Ion Therapy Technology Product Introduction
• 1.2 Global Heavy Ion Therapy Technology Market Size Forecast (2020-2031)
• 1.3 Heavy Ion Therapy Technology Market Trends & Drivers
  • 1.3.1 Heavy Ion Therapy Technology Industry Trends
  • 1.3.2 Heavy Ion Therapy Technology Market Drivers & Opportunity
  • 1.3.3 Heavy Ion Therapy Technology Market Challenges
  • 1.3.4 Heavy Ion Therapy Technology Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Heavy Ion Therapy Technology Players Revenue Ranking (2024)
• 2.2 Global Heavy Ion Therapy Technology Revenue by Company (2020-2025)
• 2.3 Key Companies Heavy Ion Therapy Technology Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Heavy Ion Therapy Technology Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Heavy Ion Therapy Technology
• 2.6 Heavy Ion Therapy Technology Market Competitive Analysis
  • 2.6.1 Heavy Ion Therapy Technology Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Heavy Ion Therapy Technology Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heavy Ion Therapy Technology as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Heavy Ion Therapy System
  • 3.1.2 Protons Therapy System
  • 3.1.3 Others
• 3.2 Global Heavy Ion Therapy Technology Sales Value by Type
  • 3.2.1 Global Heavy Ion Therapy Technology Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Heavy Ion Therapy Technology Sales Value, by Type (2020-2031)
  • 3.2.3 Global Heavy Ion Therapy Technology Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Research Institute
• 4.2 Global Heavy Ion Therapy Technology Sales Value by Application
  • 4.2.1 Global Heavy Ion Therapy Technology Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Heavy Ion Therapy Technology Sales Value, by Application (2020-2031)
  • 4.2.3 Global Heavy Ion Therapy Technology Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Heavy Ion Therapy Technology Sales Value by Region
  • 5.1.1 Global Heavy Ion Therapy Technology Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Heavy Ion Therapy Technology Sales Value by Region (2020-2025)
  • 5.1.3 Global Heavy Ion Therapy Technology Sales Value by Region (2026-2031)
  • 5.1.4 Global Heavy Ion Therapy Technology Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 5.2.2 North America Heavy Ion Therapy Technology Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 5.3.2 Europe Heavy Ion Therapy Technology Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Heavy Ion Therapy Technology Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 5.5.2 South America Heavy Ion Therapy Technology Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Heavy Ion Therapy Technology Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Heavy Ion Therapy Technology Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Heavy Ion Therapy Technology Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 6.3.2 United States Heavy Ion Therapy Technology Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Heavy Ion Therapy Technology Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 6.4.2 Europe Heavy Ion Therapy Technology Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Heavy Ion Therapy Technology Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 6.5.2 China Heavy Ion Therapy Technology Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Heavy Ion Therapy Technology Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 6.6.2 Japan Heavy Ion Therapy Technology Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Heavy Ion Therapy Technology Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 6.7.2 South Korea Heavy Ion Therapy Technology Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Heavy Ion Therapy Technology Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Heavy Ion Therapy Technology Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Heavy Ion Therapy Technology Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Heavy Ion Therapy Technology Sales Value, 2020-2031
  • 6.9.2 India Heavy Ion Therapy Technology Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Heavy Ion Therapy Technology Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Toshiba
  • 7.1.1 Toshiba Profile
  • 7.1.2 Toshiba Main Business
  • 7.1.3 Toshiba Heavy Ion Therapy Technology Products, Services and Solutions
  • 7.1.4 Toshiba Heavy Ion Therapy Technology Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Toshiba Recent Developments
• 7.2 Hitachi
  • 7.2.1 Hitachi Profile
  • 7.2.2 Hitachi Main Business
  • 7.2.3 Hitachi Heavy Ion Therapy Technology Products, Services and Solutions
  • 7.2.4 Hitachi Heavy Ion Therapy Technology Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Hitachi Recent Developments
• 7.3 CASHIM
  • 7.3.1 CASHIM Profile
  • 7.3.2 CASHIM Main Business
  • 7.3.3 CASHIM Heavy Ion Therapy Technology Products, Services and Solutions
  • 7.3.4 CASHIM Heavy Ion Therapy Technology Revenue (US$ Million) & (2020-2025)
  • 7.3.5 CASHIM Recent Developments
• 7.4 Sumitomo Heavy Industries (SHI)
  • 7.4.1 Sumitomo Heavy Industries (SHI) Profile
  • 7.4.2 Sumitomo Heavy Industries (SHI) Main Business
  • 7.4.3 Sumitomo Heavy Industries (SHI) Heavy Ion Therapy Technology Products, Services and Solutions
  • 7.4.4 Sumitomo Heavy Industries (SHI) Heavy Ion Therapy Technology Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Sumitomo Heavy Industries (SHI) Recent Developments
• 7.5 Siemens (Varian)
  • 7.5.1 Siemens (Varian) Profile
  • 7.5.2 Siemens (Varian) Main Business
  • 7.5.3 Siemens (Varian) Heavy Ion Therapy Technology Products, Services and Solutions
  • 7.5.4 Siemens (Varian) Heavy Ion Therapy Technology Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Siemens (Varian) Recent Developments

8 Industry Chain Analysis

• 8.1 Heavy Ion Therapy Technology Industrial Chain
• 8.2 Heavy Ion Therapy Technology Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Heavy Ion Therapy Technology Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Heavy Ion Therapy Technology Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer